ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Roquette, one of the world’s largest starch processing firms, has commissioned a plant in Lestrem, France, that will convert corn into its Lycadex PF brand of pyrogen-free dextrose monohydrate. Lycadex PF is used in large-volume therapeutic treatments, including dialysis, and as a vehicle for injectable drugs. The plant, which complies with current Good Manufacturing Practices, cost tens of millions of dollars. It replaces a 40-year-old facility, also in Lestrem, and increases the company’s global production capacity by more than 30%.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X